| 000 | 00933 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250512012154.0 | ||
| 264 | 0 | _c19890418 | |
| 008 | 198904s 0 0 eng d | ||
| 022 | _a0269-4727 | ||
| 024 | 7 |
_a10.1111/j.1365-2710.1989.tb00216.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, M K | |
| 245 | 0 | 0 |
_aTherapeutic progress--review XXXIV. Congestive cardiac failure. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cFeb 1989 |
||
| 300 |
_a1-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 14 _gno. 1 _gp. 1-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2710.1989.tb00216.x _zAvailable from publisher's website |
| 999 |
_c2652204 _d2652204 |
||